Hudson, MA, February 18, 2026 — Proveris Laboratories announced the launch of a redesigned website centered on its analytical and regulatory expertise in orally inhaled and nasal drug product (OINDP) development.
The updated site reflects the company’s focus on improving clarity in performance data, analytical strategy, and regulatory alignment across inhaled and nasal programs. Content has been reorganized to better reflect how analytical method development, validation, and performance characterization integrate across early feasibility, pivotal studies, and submission readiness.
Key areas of emphasis include:
• Development of reproducible and defensible test methods
• Structured analytical pathways aligned with CMC expectations
• Validation strategies consistent with global regulatory standards
• Spray and aerosol performance characterization supporting device-formulation optimization
“Our objective was not simply to update the design, but to make our scientific approach more transparent,” said Maria Smith, Director of Applications and Business Development. “Development teams need clear, defensible data to move efficiently through regulatory review. The new site reflects both the depth of our expertise and the structured, data-driven approach we bring to every project.”
The site features simplified navigation and clearer service pathways for improved visibility into Proveris Laboratories’ specialized OINDP capabilities. Visitors can explore the new website at www.proverislabs.com.
The website includes expanded technical detail on spray characterization, dose uniformity testing, and regulatory support capabilities relevant to inhaled and nasal products.
About Proveris Laboratories
Proveris Laboratories is a leader in advancing orally inhaled and nasal drug products through precision, performance, and a strong focus on patient outcomes. With more than 30 years of expertise in spray characterization and regulatory science, the company delivers the critical insights needed to optimize devices and formulations. From early feasibility studies through regulatory approval, Proveris’s contract research services help developers accelerate product development and bring high-quality therapies to market faster.
